Body Contouring Devices Market Size Worth $4.5 Billion By 2025

The global body contouring devices market size is expected to reach USD 4.5 billion by 2025 at a 13.8% CAGR over the forecast period. The global body contouring procedures market size, on the other hand, is expected to value USD 9.3 billion by 2025, expanding at a CAGR of 7.7% from 2018 to 2025, according to a new report by Grand View Research, Inc, Increased awareness regarding noninvasive and minimally invasive body contouring procedures is expected to drive the devices market in next few years.

Aging baby boomers and introduction of advanced products by the market players are other drivers of the market. In addition, advantages associated with body contouring procedures are expected to augment the market growth. Body contouring procedures help remove excess body fat and significantly affect the person’s quality of life both functionally and aesthetically.

The entry of new products in the developing regions is likely to propel the market growth during the forecast period. For instance, in April 2018, Alma Lasers launched a hands-free body contouring solution, Accentuate, during the Aesthetic & Anti-aging Medicine World Congress (AMWC) in Monaco.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/body-contouring-devices-procedures-market

Further key findings from the study suggest:

Improved accessibility to aesthetic procedures and enhanced safety due to minimally and noninvasive procedures are expected to drive the market
Noninvasive devices segment accounted for the highest market share and is expected to maintain lucrative growth during the forecast period due to the advent of new devices
The others segment is expected to observe the fastest growth due to technological advancement and noninvasive nature of these procedures. They also feature contact cooling technology that minimizes discomfort.
Clinics and spa centers segment accounted for the highest market share due to the availability of technologically advanced devices and reduced risks of hospital-acquired infections
North America accounted for the largest share of the body contouring devices market in 2017. The region is expected to maintain its dominance during the forecast period owing to the presence of major companies and the availability of well-equipped aesthetic clinics and spa centers
Some of the key companies in the global body contouring devices and procedure market are Cynosure, Inc.; Alma Lasers Ltd.; Allergan PLC; Syneron Medical Ltd.; Bausch Health Companies, Inc.; and Lumenis Ltd.

Antibiotic Resistance Market Worth $12.07 Billion by 2025

The global antibiotic resistance market size is estimated to reach USD 12.07 billion by 2025. According to a new report by Grand View Research, Inc., it is anticipated to post a CAGR of 5.6% during the forecast period. Rising burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens has been driving the market.

Biotech companies that are developing therapies for antibiotic-resistant infections include Melinta Therapeutics, Achaogen, and Nabriva Therapeutics. On the other hand, majority of large pharmaceutical companies don’t find this market lucrative enough due to slower growth in revenues for marketed drugs and lower return on investments. For instance, Novartis recently discontinued development of its antibacterial drugs for antibiotic resistance.

Manufacturers can obtain the Qualified Infectious Disease Product (QIDP) designation, which escalates the clinical review process for antibacterial therapies targeting high priority pathogens. The QIDP designation enables faster access to targeted agents and was introduced under the GAIN (Generating Antibiotic Incentives Now) Act, passed in 2012 as an extension to the U.S. FDA Safety and Innovation Act. The legislation aims to encourage the development of novel therapies for growing burden and severity of infections with antibiotic resistance.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/antibiotic-resistance-market

Further key findings from the report suggest:

In 2017, the market by cUTI disease registered significant sales due to elevated rate of resistance in extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Enterobacteriaceae and P. aeruginosa strains
The combination therapies segment, which includes fixed-dose combinations of beta lactams and beta lactamase inhibitors, is projected to witness the fastest growth rate over the forecast period
Infections due to E. coli pathogens that are ESBL-producing and carbapenem-resistant led in terms of sales revenue in 2017 due to high treatment cost
On the geographical front, North America was the dominant revenue contributor in the market in 2017. Improving reimbursement scenario with new technology add-on payment provision is promoting the use of novel products in this region
Among pharmaceutical companies, Merck, Allergan, and Pfizer were the key players with top-selling drugs in the antibiotic resistance market in 2017.

Mammalian Polyclonal IgG Antibody Market Worth $1.21 Billion By 2025

The global mammalian polyclonal IgG antibody market size is expected to reach USD 1.21 billion by 2025 expanding at a CAGR of 5.1%, according to a new report by Grand View Research, Inc. Advantages over other forms of antibodies, increasing global R&D investments, and rising adoption of novel diagnostic procedures are factors driving the market. Global rise in chronic and infectious diseases also play a key role in propelling the market growth.

Polyclonal antibodies are the most preferred choice in routine laboratory tests, such as ELISA, microarray assays, western blotting, flow cytometry, and immunohistochemistry. Production of these does not require skilled professionals and large batches can be produced as per client requirements. A polyclonal antibody can recognize multiple antigens on one epitope and therefore can be utilized in the study of various diseases ranging from cancer to metabolic diseases. Denatured proteins are often detected with the use of polyclonal antibodies.

Thus, increasing use of these products in the treatment of several chronic diseases is also anticipated to fuel growth in the near future. Rising investments by major pharma companies, such as Novartis and Roche, for the development of therapeutic antibodies and novel diagnostic techniques and for QC purposes are also driving the market growth. For instance, R&D investments by top 10 biotech companies increased from USD 8.2 billion in 2010 to USD 10.2 billion in 2016, accounting for a 13% increase.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/mammalian-polyclonal-igg-antibody-market

Further key findings from the report suggest:

Large amount of polysera obtained from goats and predominant use of these animals as hosts has contributed to its large market share in 2017
Metabolic biomarkers are expected to hold the largest market share during the forecast period due to growing prevalence of chronic diseases, such as cardiovascular diseases (CVDs) and cancer
ELISA tests provide accurate diagnosis of disease, such as AIDS, Lyme disease, syphilis, pernicious anemia, Rocky Mountain spotted fever, squamous cell carcinoma, chickenpox, shingles, and other bacterial and viral infections, than other antibody-based assays contributing to its high market share
Availability of technologically advanced equipment and presence of major market players has attributed to the North American region garnering large market share
Asia Pacific is anticipated to gain significant market share in near future due to rising R&D investment and presence of target population
Few key companies in the global mammalian polyclonal IgG antibody market include Abcam PLC; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific; Merck KgaA; Cell Signaling Technologies, Inc.; and Hoffmann-La Roche Ltd.

LPG Vaporizer Market Size Worth $1.37 Billion By 2025

The LPG vaporizer market size in North America, Europe, and Africa is expected to reach USD 1.37 billion by 2025, according to a new report by Grand View Research, Inc. The regional markets together are anticipated to witness a CAGR of 2.8% over the forecast period. Increasing demand for the equipment for efficient vaporization particularly in industrial applications is expected to have a positive impact on the market growth.

The LPG vaporizer market in North America, Europe, and Africa is characterized by the presence of major industry participants catering to various industrial, commercial, and agricultural applications. The North American market comprises several manufacturing companies with widespread distribution network around the world. The market is majorly driven by commercial applications of liquefied petroleum gas which includes hotels, resorts, and restaurants.

The regulatory trends observed by industry participants are primarily in terms of manufacturing codes or policies by several governing bodies including the National Fire Protection Association (NFPA) and American Society of Mechanical Engineers (ASME). Owing to the local regulations and safety concerns, the usage of underground storage tanks has been widespread. These tanks generally utilize the vaporizers, since underground tanks cannot absorb heat during natural vaporization from its surroundings.

Electric vaporizer was the dominant product segment in 2017 amounting for over 39% of the market share in terms of value in North America. Ability of the equipment to reach around 80% efficiency along with varied utilization in multiple industries has led to high penetration in the region.

The Europe direct-fired vaporizer market is expected to register a growth rate of 2.3% over the projected period. The most significant advantage of this product category is the utilization of LPG as the source of energy which makes it cost effective and preferred choice for small-scale applications.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/lpg-vaporizer-market

Further key findings from the report suggest:

Medium capacity equipment-ranging from 168 to 455 gal/hr-accounted for the highest share in terms of value in most countries. The segment is expected to exceed USD 21 million by 2025 in Africa
Industrial was the largest and fastest growing application segment in the market, while accounting for over 68% of the total market share in terms of revenue in 2017 in Germany
U.S. emerged as the major contributing country for North America in 2017 and accounted for over 76% of total regional market share in terms of revenue
Some of the major companies manufacturing and distributing the equipment in the North America, Europe, and Africa LPG vaporizer market include Standby Systems Inc., Algas-SDI, Pegoraro Gas Technologies Srl, and Ransome Gas Industries Inc.

Automotive Foam Market Worth $50.44 Billion By 2025

The global automotive foam market size is anticipated to reach USD 50.44 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.8% during the forecast period. Growing population, disposable income, and purchasing power parity in emerging economies of Asia Pacific are expected to propel demand for automobiles over the forecast period, thus impacting the market for automotive foam.

Transitioning lifestyles and wide availability of low-end sports models have positively impacted automotive demand from 2014 to 2017. Easy financing of automobiles owing to the EMI concept with attractive interest rates made it simpler and affordable for a medium income group consumers to purchase a vehicle of their choice. Easy availability of loans for vehicle purchase has also affected vehicle sales on similar lines. The aforementioned factors played an important role in propelling growth of the automotive industry both in developed as well as developing regions and the trend is likely to continue in the forthcoming years.

The market is expected to face instability in terms of raw material supply over the coming years owing to uncertain operation rates and plant closures by raw material manufacturers. However, relationships between manufacturers and suppliers are expected to get stronger, thus leading to stronger tie-ups at multiple distribution levels. This is expected to be a critical factor for companies to gain a competitive advantage over the forecast period.

Increasing demand for automotive foam particularly in the emerging economies of North America, Europe, Asia Pacific, and Central and South America, offers growth opportunities for the manufacturers of automotive foam and related raw materials to expand their product portfolios and market reach. The R&D initiatives undertaken by some companies to enhance their product specifications and market reach.

Substantial growth in automotive industry in Asia Pacific has fueled the demand in the automotive foam market in recent past. Significant presence of automotive and automotive foam manufacturers has played a key role in driving the product demand over the past few years and is expected to continue over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-foams-market

Further key findings from the report suggest:

In terms of revenue, PU foam type is anticipated to reach USD 2.62 billion by 2025, growing at a CAGR of 7.9% from 2018 to 2025
Seating application segment held the largest market share of over 42.8% in terms revenue in 2017. These foams are corrosion resistant and can bear various types of severe conditions, which is anticipated to bode well for growth
The U.S. automotive foam market is anticipated to reach USD 8.37 billion by 2025 owing to the presence of various manufacturers and suppliers in the country
The market is competitive with the presence of a number of global, medium, and small scale companies catering to the global and local demand
Some of the key companies include Armacell International S.A., BASF SE, Rogers Corporation, Bridgestone Corporation, The Woodbridge Group, Recticel NV, Borealis AG and Saint-Gobain. The companies use strategy such as mergers and acquisitions and portfolio expansion to gain market share.

Polyglycerol Market Size Worth $3.83 Billion By 2025

The global polyglycerol market size is expected to reach at USD 3.83 billion by 2025 expanding at a CAGR of 9.0% during the forecast period, according to a new report by Grand View Research, Inc. Polyglyceryl-3 diisostearate, polyglyceryl-3 dimer dilinoleate, and polyglyceryl-3 ricinoleate are some of the key polyglycerol 3 esters. Polyglycerol esters are plant/vegetable-derived, which makes them renewable and eco-friendly. Thus, favorable regulations pertaining to the use of polyglycerol and its esters is likely to be the major factor driving the market.Fluctuating prices of raw materials and availability of substitutes may hamper the market growth.

Moreover, the potential supply-demand gap for glycerol, which is expected in near future, followed by the presence of enzymes are expected cause hindrance to the market growth. However, rapidly growing personal care and F&B industries coupled with increasing pharmaceutical investments is expected to propel the product demand. Polyglycerol is used as cosmetic additives in personal care industry. The personal care industry is witnessing accelerated growth across the globe owing to factors like increasing disposable income, access to online platforms, and demand for anti-aging, natural, and gender-specific products. The F&B application segment accounted for 30.2% of the overall volume share in 2017.

Increasing demand for food additives in bakery products, chocolate production, and other food-related markets is expected to boost the market growth over the forecast period. Polyglycerol is also used in other applications, such as drilling fluids, textile lubricants, and wastewater treatment. Increasing oil and shale exploration activities in North America and Africa are expected to augment the market development. Also, emphasis on the improvement of water treatment facilities owing to strict government regulations is likely to propel the product demand in near future. Led by U.S., North America is a prominent regional market on account of high demand for bakery items, cosmetics, and liquid detergents in the region.

Moreover, recovering of pharmaceutical industry in U.S. is expected to boost the demand further, thereby augmenting regional market expansion. Pioneers in the global market have undertaken several strategies, such as new product development, extensive R&D activities, and expansion of customer base, to gain competitive advantage over others. For example, in July 2017, Lonza acquired Capsugel S.A. for USD 5.5 billion to boost its growth and ability to cater to customers of pharmaceutical, healthcare, and nutrition industries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/polyglycerol-market

Further key findings from the report suggest:

PG-4 was the largest product segment in 2017 and it accounted for a share of 28.2% of the overall revenue, owing to its wide application scope
Food & beverage is forecasted to be the fastest-growing application segment over forecast period
In 2017, China accounted for 45.6% of the APAC polyglycerol market, in terms of volume, due to rapid growth of the end-use industries in the country
In terms of volume, PG-10 is expected to be the fastest-growing segment in APAC owing to the product’s extensive usage in personal care formulations
Some of the key participants include Cargill, Inc.; Sakamoto Yakuhin kogyo Co., Ltd.; Spiga Nord S.p.A.; and The Good Scents Company
Companies like Spiga Nord S.p.A and Procter & Gamble are integrated across the value chain, as both these companies are raw material suppliers as well as manufacturers

Wound Debridement Market Worth $6.97 Billion By 2025

The global wound debridement market size is anticipated to reach USD 6.97 billion by 2025 at a 6.10% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising cases of injuries that require cleaning and removal of necrotic tissue are leading to increasing demand for wound debridement products.

Wound debridement products help in eliminating or reducing the load of microbes and toxins that inhibit wound healing. Increasing incidence of diabetes and obesity escalates the level of chronic wounds such as diabetic foot ulcers. As per the International Diabetes Federation, the incidence of diabetes is expected to reach 642.0 million by 2040. Prevention of wound infection is one of the major concerns for diabetic patients, making wound debridement vital. With increase in number of diabetics in U.S., demand for wound debridement is on a rise. Burns are the most common wounds and account for around 195,000 deaths annually. This, in addition to rise in awareness regarding the importance of wound debridement, is expected to positively affect the market in the coming years.

Development of advanced wound debridement products is also boosting market growth. For instance, launch of keratin-based wound care products that are used along with dressings have proven to be extremely helpful in wound re-epithelialization. The keratin matrix is absorbed in the wound and eliminates the need for dressing change. Such developments are anticipated to create growth opportunities for market players in the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wound-debridement-market

Further key findings from the study suggest:

Gels accounted for the largest share by product in 2017 due to advantages such as no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection
By wound type, diabetic foot ulcers are estimated to form the fastest growing segment due to high prevalence of diabetes. About 15.0% of diabetic foot ulcers result in amputation. Therefore, need to heal the wound in its nascent stage is necessary
Asia Pacific is anticipated to witness lucrative growth over the forecast period. Progressive economy, reforms to improve infrastructure, high unmet needs of a massive population, and availability of skilled labor is expected to drive the market in this region
Major players in this market include Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences.

Cardiovascular Ultrasound Market Worth $1.87 Billion by 2025

The global cardiovascular ultrasound (CVUS) market size is expected to reach USD 1.87 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 3.8% over the forecast period. Rising investment in the Medtech industry, increasing R&D activities, and high prevalence of cardiovascular diseases are the key factors driving market growth.

Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.

North America captured the largest market share in 2017. Favorable reimbursement framework and presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.

Some of the key players in the cardiovascular ultrasound market include Philips; GE Healthcare, Inc.; Hitachi; Fujifilm Medical Systems; Siemens Healthcare; and Canon Medical Systems Corporation.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cardiovascular-ultrasound-system-market

Further key findings from the report suggest:

Cardiovascular ultrasound market was valued at USD 1.38 billion in 2017 and is expected to grow lucratively over the forecast period
Fetal echocardiography segment is anticipated to expand at the fastest CAGR
Doppler segment was valued at USD 0.6 billion in 2017 and is anticipated to rise at a lucrative CAGR during the forecast period
Ambulatory care centers segment is expected to witness the fastest CAGR in the forthcoming years.

Arachidonic Acid Market Worth $281.0 Million By 2025

The global arachidonic acid market size is expected to reach USD 281.0 million by 2025 expanding at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Increasing product usage in baby food and health supplements is anticipated to drive the market growth. The infant formula segment is expected to witness a significant growth on account of increasing product usage in baby nutrition products. The need for appropriate amount of minerals, such as ARA and DHA, is creating more demand for ARA-based infant formula, which is likely to boost the segment growth over the coming years.

Moreover, increasing awareness regarding product benefits, as a result of various marketing activities undertaken by major companies, is likely to have a positive impact on the market growth. Increasing cases of ARA deficiency necessitates the need of a separate intake in the form of tablets, syrups, or injections. Rising awareness levels regarding the importance of maintaining the nutritive value are also likely to contribute to the global market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/arachidonic-acid-ara-market

Further key findings from the report suggest:

The global market is anticipated to reach 4.26 kilotons by 2025 expanding at a CAGR of 4.7% from 2018 to 2025
In terms of revenue, solvent form segment is projected to register a CAGR of 5.6% over the forecast period
The infant formula application segment led the global Arachidonic Acid (ARA) market in 2017
Europe regional market is projected to witness a remarkable growth over the estimated period due to the rising health consciousness and awareness about ARA-based products
Some of the key companies in the market are Cargill, Inc.; CABIO Biotech (Wuhan) Co. Ltd.; Cayman Chemical Company; Guangdong Runke Bioengineering Co. Ltd.; Koninklijke DSM N.V.; The Merck Group; and A & Z Food Additives Co. Ltd.

Commercial Seed Market Worth $92.32 Billion By 2025

The global commercial seed market size is anticipated to reach USD 92.32 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.1% over the forecast period. The increasing demand for food owing to rising global population is a significant factor driving the market. Moreover, the high yield and cost-effectiveness offered by Genetically Modified (GM) seeds are predicted to propel the product demand.

Reducing area of arable land owing to urbanization, desertification, and overall deterioration of soil quality. As a result, there is a significant need to increase the yield of the crops that are cultivated in the available land. Moreover, there are regions that face significant challenges in agricultural production owing to increasingly limited access to water resources. These factors are expected to boost adoption of highly efficient GM seeds.

The product guarantees a production, perfectly adapted to new industrial requirements, such as resistance to diseases and insects, shorter production cycles, simultaneous maturity, and homogeneity in production. The potential to replace farm seeds with commercial seeds remains significant in several countries like U.S., where agriculture is in the process of being modernized, and for certain crops in particular, such as wheat.

The commercial seed market is consolidated with top players accounting for significant market share. These players include Monsanto, Syngenta, DowDuPont, and Vilmorin & Cie. Acquisitions and launch of new facilities are the key strategies adopted by these companies. For instance, in February 2018, Syngenta completed the acquisition of Nidera seeds to gain competitive advantage and to increase market share.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/commercial-seeds-market

Further key findings from the report suggest:

Maize is anticipated to be the fastest growing product segment with a CAGR of 9.1% during the forecast period owing to its extensive utilization of the product as animal feed coupled with growing protein consumption in emerging regions
Soybean was estimated to account for a 19.6% revenue share of the commercial seed market in 2017 on account of significant consumption of soybean as oil and animal feed
In the category of genetically modified seeds, cotton is estimated to register the fastest CAGR of 9.8% due to high yield provided by Bt cotton coupled with low utilization of insecticides required in its production
Asia Pacific is predicted to expand at the fastest CAGR during the forecast period on account of the increasing requirement of higher yield on the available arable land
In February 2018, Syngenta acquired Nidera Seeds, a South American seeds manufacturer from COFCO International. This acquisition is expected to enhance Syngenta’s ability to be competitive in the industry and bring more value to its customers.